Dennis Grauer

Associate Professor and Graduate Program Director
Primary office:
Lawrence campus 785-864 4881 KU Hospital 913-588-5360
Wescoe, 6010


A native of Marysville, Kansas, Dr. Dennis Grauer earned his B.S. in Pharmacy in 1989 from the University of Kansas. He received his M.S. in Hospital Pharmacy in 1991 from The Ohio State University and completed an ASHP accredited residency program in 1991 at The Ohio State University Medical Center. In 2000, he earned his Ph.D. in Pharmacy from The Ohio State University.

Grauer completed a two-year health economic fellowship in the Solid Organ Transplantation Division at The Ohio State University. He served three years as the director of outcomes measurement and research for The Ohio State University Medical Center. He returned to the University of Kansas in 2000 as an assistant professor of pharmacy practice. While at KU, he has served as the graduate program director and has mentored more than 30 master’s level students. In addition, Grauer has served on five Ph.D Committees in the psychology department. He has significant work experience in retail, hospital, mail-order and consulting pharmacy. Outside of work, Grauer spends a great deal of time with his family in sporting activities, music and home remodeling projects.

Courses and Rotations

Required Pharm.D. Curriculm  Courses:

  • PHPR 613    Pharmacoeconomics and Outcomes Research (2 credit hours)
  • PHPR 614    Pharmacy Practice Management (3 credit hours)
  • PHPR 619    Health Systems (3 credit hours)

Elective Pharm.D. Curriculum Courses (all 1 credit hour):

  • PHPR 514    Communication and Counseling
  • PHPR 516    Public Health and Pharmacy
  • PHPR 518    Cultural Competency in Pharmacy
  • PHPR 519    Business Planning for Pharmacists

Required Master’s Degree Curriculum Courses:

  • PHPR 855    Evaluation of Health Care Programs and Services (3 credit hours)
  • Research and independent study credit hours for both professional and graduate degree students

Professional Leadership and Service

  • American College of Clinical Pharmacy
  • American Pharmaceutical Association
  • American Society of Health System Pharmacists
  • International Society for Pharmacoeconomic and Outcomes Research
  • Kansas Pharmacists Association
  • Kansas Rural Health Association (Founding Member)
  • Kansas Council of Health System Pharmacists
  • National Community Pharmacists Association
  • National Rural Health Association
  • Phi Lambda Sigma National Pharmacy Leadership Society
  • Chair, Data and Safety Monitoring Board, The University of Kansas Hospitals
  • Member, State of Kansas Medicaid Program, Drug Utilizations Review Board
  • Advisor, KU School of Pharmacy, National Community Pharmacists Association Chapter
  • Chair, National Rural Health Association, Medication Use in Rural America Conference

Specializations

The study and evaluation of economic, clinical and patient-reported health outcomes produced by decision-making processes within the health care delivery system with a specific focus on the delivery of pharmaceutical services to the patient

  • Evaluation of drug therapy and medication use processes using pharmacoeconomic analyses and quality of life
  • Measurement of outcomes (effectiveness) of health care treatments
  • Improvement of quality of health care processes
  • Measurement and prediction of adherence to medication regimens
  • Measurement and impact of health literacy on adult health care consumers
  • Development of a rural research network
  • Rural pharmaceutical care evaluation.

Selected Awards and Honors

  • Accreditation Evaluation for Research Protection Program Commendation, Data and Safety Monitoring Board, The University of Kansas Hospitals (2010)
  • HOPA Literature Award.  Albumin prophylaxis for ifosfamide-induced encephalopathy. Kettle JK, Grauer DW, Folker TL, O’Neal N, Henry DW, Williams CB. Pharmacotherapy (2010).
  • Faculty Advisor, NCPA Business Plan Competition, 2nd Runner-Up (2008)

Selected Publications

  • Barnes BJ, Howard PA, Lai AM, Grauer D.W., Kramer JB, Daon E, Zorn GL, Dawn B and Muelebach GF. Nicardipine versus sodium nitroprusside for post-cardiac surgery hypertension: an evaluation of effectiveness and postoperative costs. Hospital Pharmacy.  2012;47(8):617-625
  • McClure SR, O’Neal BC, Grauer D.W., Couldry RJ and King AR. Compliance with recommendations for prevention and detection of controlled-substance diversion in hospitals. Am J Health Syst Pharm. 2011;68(8):689-94
  • Kettle JK, Grauer D., Folker TI, O’Neal N, Henry DW and Williams CB.  Effectiveness of exogenous Albumin administration for the prevention of ifosfamide-induced encephalopathy.  Pharmacotherapy. 2010;30(8):812-817
  • King AR, Russett FS, Generali JA and Grauer D.W. Evaluation and implications of natural product use in preoperative patients: a retrospective review. BMC Complimentary and Alternative Medicine. 2009;9:38-46

Selected Presentations

  • Bivona C, Klenke S, Lubanski P, Johnson G, Grauer D., Williams C.  Effect of carboplatin dosing modifications on outcomes in gynecologic cancer: a retrospective study. In: 2012 HOPA 8th Annual Conference Proceedings. Orlando, FL, 2012
  • Katz G, Williams C, Irvine E, Ford S, Grauer D. Evaluation of daptomycin use in VRE positive patients with febrile neutropenia in the bone marrow transplant unit.  In:  2012 8th Annual Conference Proceedings.  Orlando, FL, 2012
  • Svoboda DJ, Klenke SE, Williams C, Henry D, Grauer D. Pilot study to evaluate patient-controlled delivery system for antiemetics in highly emetogenic oncology chemotherapy protocols. In: 2012 HOPA 8th Annual Conference. 2012;Orlando, FL
  • Lubanski P, Casey L, Grauer D., O’Neal B, Henry D, Williams C. Retrospective chart review comparing outcomes with decitabine vs azacitidine in patients with myelodysplastic syndrome. In: 2011 HOPA 7th Annual Conference Proceedings. 2011;Salt Lake City, UT:Abstract TR7
  • Trivedi J, Irvine E, Grauer D., O’Neal B, Henry D, Williams CB. Retrospective chart review evaluating outcomes of primary induction and salvage therapies for patients with elderly (age > 60) acute myeloid leukemia. In: 2011 HOPA 7th Annual Conference Proceedings.  2011;Salt Lake City, UT:Abstract TR7
     

2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to needy Kansans during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU
KU Today